CAVA Crowd Favorites, Made Diabetes-Smart: What to Order
If CAVA is one of your favorite spots to dine in, here’s our little guide to help you amp up the flavor while being…
This study is for people who are overweight or have obesity with at least one weight-related health condition and do not have Type 2 Diabetes. People with prediabetes may be eligible. The study is testing an investigational once-weekly injection to see if it is safe and effective for weight reduction. Participants will continue their current medications and receive either the study medication or a placebo.
To take part in the study, participants should:
CEO and Medical Director
Director of Clinical Research
Clinical Research Coordinator
Navigator/Study Start-up Manager
Clinical Research Coordinator
Clinical Research Coordinator